Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1991;18:101-110

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kimura, K.
Right arrow Articles by Sugimoto, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kimura, K.
Right arrow Articles by Sugimoto, T.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*CAPTOPRIL
*HYDRALAZINE HYDROCHLORIDE
*TRICHLORMETHIAZIDE
Medline Plus Health Information
*High Blood Pressure

Hypertension, Vol 18, 101-110, Copyright © 1991 by American Heart Association


ARTICLES

Renal arteriolar diameters in spontaneously hypertensive rats. Vascular cast study

K Kimura, A Tojo, H Matsuoka and T Sugimoto
Second Department of Internal Medicine, Faculty of Medicine, University of Tokyo, Japan.

The relation between the arteriolar diameters and hypertensive glomerulosclerosis was studied by using microvascular casts and histological evaluation. Spontaneously hypertensive rats 4 weeks of age were divided into three groups: nontreated, captopril (40 mg/kg/day)- treated, and trichlormethiazide (1 mg/kg/day) with hydralazine (20 mg/kg/day)-treated. Wistar-Kyoto rats served as controls. At 6 weeks old, the captopril-treated rats showed a lower blood pressure and a larger afferent arteriolar diameter compared with the control rats. At 20 weeks old, the nontreated group exhibited hypertension and a lower arteriolar diameter ratio (afferent to efferent, 0.89 versus 1.22 in control group) because of afferent constriction and efferent dilatation, seen equally in the outer and inner cortexes. Glomerulosclerosis was accentuated only in the inner cortex of the nontreated group (score, 63 versus 29 in control group). In the two treated rat groups, the blood pressure was reduced and arteriolar diameter ratios were similar to those in the control group (1.18 and 1.26). The sclerosis score in the trichlormethiazide with hydralazine- treated rats (score, 26) was lower than in the nontreated rats but not the captopril-treated rats (score, 36). These results indicated that 1) in the hypertensive rats, despite a reduced diameter ratio, glomerulosclerosis was more severe in the inner cortex; 2) two therapies reduced blood pressure and reversed the arteriolar changes, but a decrease in glomerulosclerosis was seen only in the trichlormethiazide with hydralazine-treated rats; and 3) for development of glomerulosclerosis, factors other than hemodynamics may be important in addition to intraglomerular pressure.


This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
D. A. Nordsletten, S. Blackett, M. D. Bentley, E. L. Ritman, and N. P. Smith
Structural morphology of renal vasculature
Am J Physiol Heart Circ Physiol, July 1, 2006; 291(1): H296 - H309.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
T. Yamamoto, Y. Tomura, H. Tanaka, and F. Kajiya
In vivo visualization of characteristics of renal microcirculation in hypertensive and diabetic rats
Am J Physiol Renal Physiol, September 1, 2001; 281(3): F571 - F577.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
A. S. Reddi, V. R. Nimmagadda, and R. Arora
Effect of Antihypertensive Therapy on Renal Artery Structure in Type 2 Diabetic Rats With Hypertension
Hypertension, May 1, 2001; 37(5): 1273 - 1278.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
M. Sabbatini, L. Vitaioli, E. Baldoni, and F. Amenta
Nephroprotective Effect of Treatment with Calcium Channel Blockers in Spontaneously Hypertensive Rats
J. Pharmacol. Exp. Ther., September 1, 2000; 294(3): 948 - 954.
[Abstract] [Full Text]


Home page
HypertensionHome page
F. Tomoda, M. Takata, H. Kinuno, S. Tomita, K. Yasumoto, and H. Inoue
Renal Structural Properties in Prehypertensive Dahl Salt-Sensitive Rats
Hypertension, July 1, 2000; 36(1): 68 - 72.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
M. Sabbatini, A. Leonardi, R. Testa, L. Vitaioli, and F. Amenta
Effect of Calcium Antagonists on Glomerular Arterioles in Spontaneously Hypertensive Rats
Hypertension, March 1, 2000; 35(3): 775 - 779.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
J. Zicha and J. Kunes
Ontogenetic Aspects of Hypertension Development: Analysis in the Rat
Physiol Rev, October 1, 1999; 79(4): 1227 - 1282.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
J. R. NYENGAARD
Stereologic Methods and Their Application in Kidney Research
J. Am. Soc. Nephrol., May 1, 1999; 10(5): 1100 - 1123.
[Abstract] [Full Text]


Home page
HypertensionHome page
G. Bergstrom, I. Johansson, K. M. Stevenson, M. M. Kett, and W. P. Anderson
Perindopril Treatment Affects Both Preglomerular Renal Vascular Lumen Dimensions and In Vivo Responsiveness to Vasoconstrictors in Spontaneously Hypertensive Rats
Hypertension, April 1, 1998; 31(4): 1007 - 1013.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
K. Skov, J. Fenger-Gron, and M. J. Mulvany
Effects of an Angiotensin-Converting Enzyme Inhibitor, a Calcium Antagonist, and an Endothelin Receptor Antagonist on Renal Afferent Arteriolar Structure
Hypertension, September 1, 1996; 28(3): 464 - 471.
[Abstract] [Full Text]


Home page
HypertensionHome page
M. Notoya, M. Nakamura, and K. Mizojiri
Effects of Lisinopril on the Structure of Renal Arterioles
Hypertension, March 1, 1996; 27(3): 364 - 370.
[Abstract] [Full Text]